Related Experiment Video
Updated: Dec 28, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
The corticotropin releasing factor system in cancer: expression and pathophysiological implications
Athina Kaprara1, Kalliopi Pazaitou-Panayiotou, Alexandros Kortsaris
1Anticancer Hospital Theagenio, Thessaloniki, Greece.
The corticotropin-releasing factor (CRF) system plays a role in human cancer growth, metastasis, and immune responses. Targeting CRF receptors offers potential new anticancer therapies.
Area of Science:
- Oncology
- Neuroendocrinology
Background:
- Malignant tumors utilize regulatory networks for growth.
- The corticotropin-releasing factor (CRF) system, a key stress mediator, is gaining attention for its potential role in cancer.
Purpose of the Study:
- To review the literature on the involvement of the CRF system in human cancer development.
- To explore the potential of targeting the CRF system for anticancer therapies.
Main Methods:
- Literature review of studies investigating the CRF system in cancer.
- Analysis of the biological roles of CRF system components in tumor progression.
Main Results:
- Evidence suggests the CRF system is implicated in regulating cancer growth, metastasis, and angiogenesis.
- Local expression of CRF receptors may influence immune parameters in the tumor microenvironment.
Conclusions:
- The CRF system represents a potential therapeutic target for novel anticancer strategies.
- Exploiting CRF receptor pathways could lead to new treatments for various human cancers.
Related Concept Videos
Hypothalamic-Pituitary Axis
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Physiological Foundation of Stress
Role of the Sympathetic Nervous System
Adrenaline triggers the...
Regulation of Hormone Secretion
Humoral...

